Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma.

MLA

Kolstad, Arne, et al. “Sequential Intranodal Immunotherapy Induces Antitumor Immunity and Correlated Regression of Disseminated Follicular Lymphoma.” Blood, vol. 125, no. 1, Jan. 2015, pp. 82–89. EBSCOhost, https://doi.org/10.1182/blood-2014-07-592162.

APA

Kolstad, A., Kumari, S., Walczak, M., Madsbu, U., Hagtvedt, T., Bogsrud, T. V., Kvalheim, G., Holte, H., Aurlien, E., Delabie, J., Tierens, A., & Olweus, J. (2015). Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma. Blood, 125(1), 82–89. https://doi.org/10.1182/blood-2014-07-592162

Chicago

Kolstad, Arne, Shraddha Kumari, Mateusz Walczak, Ulf Madsbu, Trond Hagtvedt, Trond Velde Bogsrud, Gunnar Kvalheim, et al. 2015. “Sequential Intranodal Immunotherapy Induces Antitumor Immunity and Correlated Regression of Disseminated Follicular Lymphoma.” Blood 125 (1): 82–89. doi:10.1182/blood-2014-07-592162.